SCHEMBL25323786

SCHEMBL25323786

Cn1cc(-c2ccnc3c2ccn3S(=O)(=O)c2ccccc2)c(Br)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.46
HTR6 P50406 12/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
MET P08581 1/20 0.38
DRD2 P14416 2/20 0.37
HTR2A P28223 2/20 0.37
PKM P14618 1/20 0.36
PIK3C3 Q8NEB9 1/20 0.36
HTR1A P08908 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC9 Q9UKV0 1/20 0.35
HDAC5 Q9UQL6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30509465 1.00 CYP2C19 (0.46) CYP2C19HTR6L3MBTL1METDRD2
SCHEMBL25322767 0.87 CYP2C19 (0.46) CYP2C19HTR6L3MBTL1METDRD2
SCHEMBL30543160 0.87 CYP2C19 (0.46) CYP2C19HTR6L3MBTL1METDRD2
SCHEMBL30543146 0.85 CYP2C19 (0.44) CYP2C19HTR6L3MBTL1METDRD2
SCHEMBL25323481 0.85 CYP2C19 (0.44) CYP2C19HTR6L3MBTL1METDRD2
SCHEMBL25323894 0.82 CYP2C19 (0.40) CYP2C19HTR6L3MBTL1METDRD2
SCHEMBL30543163 0.82 CYP2C19 (0.40) CYP2C19HTR6L3MBTL1METDRD2
SCHEMBL25324146 0.81 CYP2C19 (0.41) CYP2C19HTR6L3MBTL1METDRD2
SCHEMBL25323498 0.81 CYP2C19 (0.41) CYP2C19HTR6L3MBTL1METPKM
SCHEMBL25324807 0.81 CYP2C19 (0.41) CYP2C19HTR6L3MBTL1METDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
EP-4214199-A1 CASEIN KINASE 1 DELTA MODULATORS JANSSEN Pharmaceutica NV (BE) 2023-07-26 EP disclosed
CN-116490503-A Casein kinase 1 delta modulators 詹森药业有限公司 2023-07-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230339900-A1 CASEIN KINASE 1 DELTA MODULATORS CSNK1D, CSNK1A1, CSNK2A1 CYP2C19 3167/4885HTR6 2574/4885L3MBTL1 2087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.